2022

PRC faculty awarded new grants

Congratulations to our PRC Faculty, Maura Kepper and Steph Mazzucca, for receiving new grant awards. Details about the grant awards are below.

Maura Kepper 

Funder: Wash U Center for Dissemination & Implementation and Implementation Science Center for Cancer Control 

Title: Adapting and Implementing a Novel Digital Health Tool to Promote Behavior Change and Improve Cancer Risk in Rural Missouri 

Aim 1: Employ a stakeholder-driven approach to adapt PREVENT for the rural context.  

1a. Engage CHWs and community organizations to add local resources to PREVENT’s existing interactive resource map.  

1b. Use ethnographic contextual inquiry (guided tours and interviews) to optimize PREVENT for the workflow and clinic setting.  

1c. Assemble an advisory board with multiple stakeholder groups to co-develop a sustainable, workflow-aware implementation and evaluation plan. 

1 year, $40K 

Steph Mazzucca 

Funder: NIH/NCI 

Title: Improving cancer prevention and control through academic-local public health department partnerships 

Aim 1: Understand the structures of and processes within AHD partnerships, and the contextual factors that influence the ability of AHD partnerships to implement EBPPs. 

We will survey an existing, nationwide network of AHD partnerships to identify 4 high- and 4 low-performing partnerships based on their implementation of cancer-related EBPPs. We will use qualitative interviews and document reviews to refine our existing set of strategies to improve the use of EBPPs (e.g., facilitation needed) based on characteristics of successful and unsuccessful partnerships. 

Research Questions: How do successful AHD partnerships build and maintain individual skills and organizational capacity required to implement and evaluate implementation of EBPPs? What contextual factors promote or hinder a successful AHD partnership?  

Aim 2: Test the effectiveness of strategies designed to increase the implementation of EBPPs for cancer prevention and control by strengthening AHD partnerships. 

We will conduct a group-randomized study (total N=28 AHD partnerships) to evaluate the effect of strategies to increase implementation of cancer control and prevention EBPPs by supporting AHD partnerships. A mixed methods approach will be used to evaluate changes in AHD partnerships and understand how contextual factors may have impacted the AHD partnership’s ability to support EBPP adoption. 

Hypothesis: Two years post randomization, LHDs within partnerships randomized to receive supports to improve AHD partnerships will have implemented significantly more cancer-related EBPPs compared to LHDs within partnerships randomized to the control arm.  

5 years, $3 million (with an option for two additional years)